# US 2013/0280348 A1 · Carbon dioxide and saline nasal delivery methods and treatments

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0280348 A1
- Document ID: US20130280348A1
- Status: Published application
- Kind: A1
- Application number: 13/506,426
- Filed: 2012-04-18
- Published: 2013-10-24
- Earliest claimed: 2012-04-18
- Assignees: Glynn Tech, Inc.
- Inventors: Kenneth P. Glynn
- Web page: https://patentgrep.com/patent/US20130280348A1

## CPC

- A61K 33/00: Medicinal preparations containing inorganic active ingredients
- A61K 9/0043: {Nose}
- A61K 33/14: Alkali metal chlorides; Alkaline earth metal chlorides
- A61P 11/02: Nasal agents, e.g. decongestants
- A61P 25/00: Drugs for disorders of the nervous system
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

Methods for treating ailments in a patient in need thereof includes the step of directing a therapeutic, non-inhaled dosage to at least one nasal cavity of the patient through a flow regulating device while the patient refrains from inhaling. The dosage includes a saline fluid and a gas containing carbon dioxide, wherein the therapeutic, non-inhaled dosage is delivered at a flow rate from 1 cc/sec to 20 cc/sec for a duration of 2 to 30 seconds.

## Claims

### Claim 1

A method for treating head ailments in a patient in need thereof, said method comprising:
directing a therapeutic, non-inhaled dosage to at least one nasal cavity of said patient through a flow regulating device, said dosage including a saline fluid and a gas containing carbon dioxide, wherein the therapeutic, non-inhaled dosage is delivered at a flow rate from 1 cc/sec to 20 cc/sec for a duration of 2 to 30 seconds, while said patient is substantially refraining from inhaling.

### Claim 2 (depends on 1)

The method of claim 1, wherein said treated head ailment is selected from the group consisting of rhinitis, conjunctivitis, common cold and sinusitis.

### Claim 3 (depends on 1)

The method of claim 1, wherein said method is for treating rhinitis and the rhinitis is allergic rhinitis.

### Claim 4 (depends on 1)

The method of claim 1, wherein said head ailment is headache.

### Claim 5 (depends on 1)

The method of claim 1, wherein said flow regulating device is a single dose dispenser with a pressure control valve for released flow regulation.

### Claim 6 (depends on 5)

The method of claim 5, wherein said flow regulating device is a multiple dose dispenser with a pressure control valve for released flow regulation.

### Claim 7 (depends on 1)

The method of claim 1, wherein multiple dose dispenser further includes a dosage amount control mechanism and activator to limit dosage release amount for each activation.

### Claim 8 (depends on 1)

The method of claim 1, wherein the duration is 5 to 10 seconds per nasal cavity.

### Claim 9 (depends on 1)

The method of claim 1 wherein the dose is repeated from 1 to 10 times.

### Claim 10 (depends on 1)

The method of claim 1 wherein the duration is 2 to 15 seconds per nasal cavity.

### Claim 11 (depends on 1)

The method of claim 1 wherein the flow rate is from 2 cc/sec to 10 cc/sec.

### Claim 12 (depends on 1)

The method of claim 1 wherein the flow rate is from 1 cc/sec to 5 cc/sec.

### Claim 13 (depends on 1)

The method of claim 1 wherein the flow rate is from 4 cc/sec to 5 cc/sec.

### Claim 14 (depends on 1)

The method of claim 1 wherein the flow rate is 10 cc/sec.

### Claim 15 (depends on 1)

The method of claim 1 wherein the gas comprises at least 50% carbon dioxide.

### Claim 16 (depends on 1)

The method of claim 1 wherein the gas comprises at least 70% carbon dioxide.

### Claim 17 (depends on 1)

The method of claim 1 wherein the gas comprises at least 95% carbon dioxide.

### Claim 18 (depends on 1)

The method of claim 1 wherein the gas comprises substantially pure carbon dioxide.
